Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten J Maier

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Biochemical Pharmacology|November 9, 2016
Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418Isabelle V Maucher, Michael Rühl, Simon B M Kretschmer, et al.
Antioxidants & Redox Signaling|July 13, 2017
Drug-Mediated Intracellular Donation of Nitric Oxide Potently Inhibits 5-Lipoxygenase: A Possible Key to Future Antileukotriene TherapyJessica Roos, Marcus Peters, Isabelle V Maucher, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2018
Nitro-fatty acids are formed in response to virus infection and are potent inhibitors of STING palmitoylation and signalingAnne Louise Hansen, Gregory J Buchan, Michael Rühl, et al.
The Journal of Clinical Investigation|May 5, 2011
Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouseDontscho Kerjaschki, Zsuzsanna Bago-Horvath, Margaretha Rudas, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Biochemical Pharmacology|November 9, 2016
Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418Isabelle V Maucher, Michael Rühl, Simon B M Kretschmer, et al.
Antioxidants & Redox Signaling|July 13, 2017
Drug-Mediated Intracellular Donation of Nitric Oxide Potently Inhibits 5-Lipoxygenase: A Possible Key to Future Antileukotriene TherapyJessica Roos, Marcus Peters, Isabelle V Maucher, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2018
Nitro-fatty acids are formed in response to virus infection and are potent inhibitors of STING palmitoylation and signalingAnne Louise Hansen, Gregory J Buchan, Michael Rühl, et al.
The Journal of Clinical Investigation|May 5, 2011
Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouseDontscho Kerjaschki, Zsuzsanna Bago-Horvath, Margaretha Rudas, et al.
Pageof 5